SynthesisBMC psychiatry2026
Oxytocin dysfunction in severe mental illnesses following adverse childhood experiences: a systematic review.
Synthesis in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdverse childhood experiences (ACEs) are recognized as a transdiagnostic risk factor for developing severe mental illnesses (SMIs), including schizophrenia (SCZ), major depressive disorder (MDD), or bipolar disorder (BD). However, the specific associations and underlying mechanisms linking ACEs and SMIs remain unclear. In recent years, oxytocin (OXT), a neuropeptide known for its role in social bonding and stress regulation, has emerged as a crucial pathway linking SMIs and ACEs. This study aimed to investigate the relationship between SMIs among individuals with a history of childhood adversity and oxytocin dysregulation both at biochemical and genetic levels.
methodWe conducted a systematic review assessing OXT measurements or the role of OXT receptor gene (OXTR) polymorphisms in individuals with or without SMIs and a history of ACEs. A comprehensive search of four databases (PsycINFO, MEDLINE, Web of Science, and PubMed) was undertaken, adhering to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and the review protocol was registered in PROSPERO: CRD42024555819. Comparisons were made between SMI groups and healthy controls (HCs). Data were extracted and appraised independently by two reviewers using the Mixed Methods Appraisal Tool (MMAT). Primary outcomes included group differences in ACE scores, a measure that reflects the type, quantity, and severity of childhood trauma. We also compared group differences in OXT levels, genotype frequencies of OXTR single-nucleotide polymorphisms (SNPs), thereby, exploring links between ACEs, OXT-OXTR signalling, and SMIs.
resultsOf 545 reports identified by the search, 14 studies with 5,624 participants met the inclusion criteria. Most studies (n = 13; 92.86%) reported that individuals with SMIs exhibited significantly higher ACE scores than HCs. Among the nine of fourteen studies that measured OXT levels, 66% (n = six of nine) reported lower OXT levels in SMIs irrespective of the subgroups, including in SCZ and borderline personality disorder (BPD). Several polymorphisms in OXTR were found to have a modulatory effect on SMI outcomes. A subset of SNPs conferred susceptibility, whereas others served as protective factors.
conclusionThis review highlights associations between OXT system and SMIs with a history of ACE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.